The novel EBV biomarkers for prediction of refractory nasal polyposis after functional endoscopic sinus surgery
- Conditions
- asal polyposis patients who were required to surgery.Nasal polyp, Endoscopic sinus surgery, EBV, recurrence, refractory
- Registration Number
- TCTR20220131002
- Lead Sponsor
- Fundamental Fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 96
Inclusion Criteria
nasal polyposis patients who were scheduled for FESS
Exclusion Criteria
1.patients who received systemic steroids before surgery 4 weeks
2.patients with antrochoanal
3.allergic fungal sinusitis patients
4.patients with nasal and nasopharyngeal tumor
5.patients with autoimmune disease or received immunotherapy
6.patients received chemotherapy and/or radiotherapy in the head and neck field
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method recurrent nasal polyp at 1 week, 1 mo, 3mo,6 mo, 9 mo,12 mo,15 mo, 18 mo Lund Kenedy score
- Secondary Outcome Measures
Name Time Method clinical post surgery at 1 wk, 1 mo, 3 mo, 6mo, 9 mo,12mo,15mo,18 mo SNOT 22